2m 2m 2m 2m 2m 2m 2m
THERAPEUTICSMD (TXMD)
NASDAQ
$2.04-$0.02 (-0.97%)
Price as of Aug 21, 2026 6:18 PM EDT- $23.8MMarket Cap
- 87.29%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
THERAPEUTICSMD (TXMD)
$2.04-$0.02 (-0.97%)
TXMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.06 | ||
Change | $0.00 (0.00%) | ||
Open | $2.06 | ||
High | $2.07 | ||
Low | $2.04 | ||
Previous Close | $2.06 | ||
Volume | 3,430 | ||
30-Day Average Volume | 19,176 | ||
1-Week Change | -0.48% | ||
1-Month Change | 0.98% | ||
1-Year Change | 87.29% | ||
3-Year Change | -46.07% | ||
5-Year Change | -94.60% | ||
Fundamentals | |||
Shares Outstanding | 11.6M | ||
Total Assets | $37.5M | ||
Market Cap | $23.8M | ||
Enterprise Value | $14.7M | ||
Period: QTR TTM FY | |||
Revenue | $869,000.00 | ||
Net Income | $164,000.00 | ||
Free Cash Flow | $770,000.00 | ||
EBIT | $164,000.00 | ||
EBITDA | $259,000.00 | ||
Net Working Capital | $11.1M | ||
EPS | $0.01 | ||
Enterprise Value/EBITDA | 57 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 1 | ||
P/E | 206 | ||
PEG | N/A | ||
Price/Free Cash Flow | 31 | ||
Price/Operating Cash Flow | 31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 05/09/2022 | ||
Earnings & Revenue